Výsledky vyhledávání

Skin rash in patients treated with neoadjuvant erlotinib (Tarceva) in resectable non-small cell lung cancer: Predictor for tumor response and survival?

Autor: Van Gool MH, Burgers JA, Sikorska K, Schaake EE, Aukema TS, Klomp HM, NEL study Group

Publikováno v: Journal of Cancer Research & Therapy, Vol 5, Iss 7, Pp 45-49 (2017)

Background: Skin rash during treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI) has been reported to be predictive for response and survival in patients with advanced non-small cell lung cancer (NSCLC). The aim of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::466819e5d4d2c4f34a23198bd4894234
https://doi.org/10.14312/2052-4994.2017-9

Zobrazit plný text záznamu

Akademický článek

Spinal-cord stimulation in critical limb ischaemia: a randomised trial. ESES Study Group.

Autor: Klomp HM (AUTHOR), Spincemaille GHJ (AUTHOR), Steyerberg EW (AUTHOR), Habbema JDF (AUTHOR), van Urk H (AUTHOR), Klomp, H M¹ (AUTHOR), Spincemaille, G H (AUTHOR), Steyerberg, E W (AUTHOR), Habbema, J D (AUTHOR), van Urk, H (AUTHOR)

Publikováno v: Lancet. 3/27/1999, Vol. 353 Issue 9158, p1040-1044. 5p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Technical data and complications of spinal cord stimulation: data from a randomized trial on critical limb ischemia

Autor: Spincemaille, GHJJ, Klomp, HM (Houke), Steyerberg, Ewout, van Urk, H, Habbema, Dik, ESES, STUDYGROUP

Publikováno v: Stereotactic and Functional Neurosurgery, 74, 63-72. Karger

This study was done to evaluate the effect of spinal cord stimulation (SCS) on critical limb ischemia and to report technical problems and complications. One hundred and twenty patients with critical limb ischemia were eligible for randomization betw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c6b8759f96cdab9cfe64e8ef3e93bd3
https://pubmed.ncbi.nlm.nih.gov/11251396

Zobrazit plný text záznamu